Shear Stress and Metabolic Disorders-Two Sides of the Same Plaque

Minchun Jiang1,2, Huanyu Ding1,2, Yu Huang1,2

  • 1Heart and Vascular Institute, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.

Insights

Shear stress and metabolic disorders drive atherosclerosis through complex interactions. Understanding these links may reveal new therapeutic targets for preventing plaque buildup and related vascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Biomedical Engineering
  • Metabolic Medicine

Background:

  • Atherosclerosis is linked to both arterial shear stress and metabolic disorders.
  • Lesions often form in areas with abnormal blood flow patterns (low/oscillatory shear stress).
  • Metabolic dysfunctions significantly contribute to atherosclerotic plaque development.

Purpose of the Study:

  • To explore the intricate relationship between shear stress and metabolic disorder in atherosclerosis.
  • To highlight the mechanisms, including mechanotransduction and epigenetic regulation, involved in atherogenesis.
  • To investigate the crosstalk between these two major drivers of atherosclerosis.

Main Methods:

  • Review of accumulated evidence on biomechanical forces and metabolic disorder in atherogenesis.
  • Analysis of recent studies focusing on the interplay between shear stress and metabolic factors.
  • Examination of molecular pathways like oxidative stress and inflammation.

Main Results:

  • Shear stress and metabolic disorder are interconnected factors in atherosclerosis.
  • Their crosstalk can exacerbate proatherogenic effects, increasing oxidative stress and inflammation.
  • The complex network of interactions requires further elucidation.

Conclusions:

  • Understanding the crosstalk between shear stress and metabolic disorder is crucial for managing atherosclerosis.
  • Mediators of this interaction represent potential therapeutic targets.
  • Advanced omics approaches are needed for developing novel anti-atherosclerosis strategies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
283
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
125
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
563
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
139
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
123
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87